Joseph Ross, MD, MHS
Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management)Cards
Contact Info
General Internal Medicine
P.O. Box 208093
New Haven, CT 06520-8093
United States
Education
Yale School of Medicine (2006)
Albert Einstein College of Medicine (2001)
University of Rochester (1996)
Training
Montefiore Medical Center (2004)
Contact Info
General Internal Medicine
P.O. Box 208093
New Haven, CT 06520-8093
United States
Education
Yale School of Medicine (2006)
Albert Einstein College of Medicine (2001)
University of Rochester (1996)
Training
Montefiore Medical Center (2004)
Contact Info
General Internal Medicine
P.O. Box 208093
New Haven, CT 06520-8093
United States
Education
Yale School of Medicine (2006)
Albert Einstein College of Medicine (2001)
University of Rochester (1996)
Training
Montefiore Medical Center (2004)
About
Copy Link
Titles
Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management)
Biography
Joseph S. Ross, MD, MHS, is a Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management), a member of the Center for Outcomes Research and Evaluation (CORE) at the Yale-New Haven Hospital, and an Co-Director of the National Clinician Scholars program (NCSP) at Yale. He completed his undergraduate degrees in biological science: neuroscience and psychology at the University of Rochester and his medical degree at the Albert Einstein College of Medicine, Bronx, NY. After completing his post-graduate training in primary care internal medicine at Montefiore Medical Center in Bronx, NY, Dr. Ross was a fellow in the Robert Wood Johnson Foundation Clinical Scholars program at Yale, earning a Master’s degree in health sciences research. Using health services research methods, Dr. Ross’s research focuses on examining factors which affect the use or delivery of recommended ambulatory care services for older adults and other vulnerable populations, evaluating the impact of state and federal policies on the delivery of appropriate and higher quality care, and addressing issues related to pharmaceutical and medical device regulation, evidence development, postmarket surveillance, and clinical adoption. In addition, he collaborates with a multi-disciplinary team of investigators under contract for the Centers for Medicare and Medicaid Services to develop statistical models that are used to measure and publicly report hospital and ambulatory care clinical outcomes using administrative data. Dr. Ross co-directs the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI), the Yale Open Data Access (YODA) Project, the Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT) at Yale Law School, and leads efforts at Yale-New Haven Health System in collaboration with the National Evaluation System for health Technology. Dr. Ross is currently a Deputy Editor at JAMA, co-founder of medRxiv, Chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC), and a member of the New England Comparative Effectiveness Public Advisory Council (New England CEPAC) for ICER.
Appointments
General Internal Medicine
ProfessorPrimaryHealth Policy & Management
ProfessorSecondaryInstitution for Social and Policy Studies
ProfessorSecondary
Other Departments & Organizations
- Cancer Prevention and Control
- Center for Outcomes Research & Evaluation (CORE)
- Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT)
- General Internal Medicine
- Health Policy & Management
- Institution for Social and Policy Studies
- Internal Medicine
- National Clinician Scholars Program
- Regulatory Affairs Track
- Yale New Haven Health System
- Yale School of Public Health
- Yale Ventures
Education & Training
- MHS
- Yale School of Medicine (2006)
- Postgraduate Training
- Montefiore Medical Center (2004)
- MD
- Albert Einstein College of Medicine (2001)
- BS
- University of Rochester (1996)
- BA
- University of Rochester (1996)
Research
Copy Link
Overview
Medical Research Interests
Public Health Interests
ORCID
0000-0002-9218-3320
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Harlan Krumholz, MD, SM
Reshma Ramachandran, MD, MPP, MHS
Jeph Herrin, PhD
Jennifer E Miller, PhD
Jeptha Curtis, MD
Cary P Gross, MD
Quality of Health Care
Delivery of Health Care
Health Services Research
Publications
2026
Secondary use and scholarly impact of a portfolio of clinical trials with shared individual participant level data: cross sectional study.
Taherifard E, Mooghali M, Hakimian H, Mane S, Fu M, Bamford S, Berlin J, Childers K, Desai N, Gross C, Hewens D, Lehman R, Ritchie J, Sargood T, Waldstreicher J, Wallach J, Willeford M, Krumholz H, Ross J. Secondary use and scholarly impact of a portfolio of clinical trials with shared individual participant level data: cross sectional study. The BMJ 2026, 394: e100460. PMID: 42686366, DOI: 10.1136/bmj-2026-100460.Peer-Reviewed Original ResearchCitationsAltmetricValuation Adjustments for Services Reviewed by the Relative Value Scale Update Committee
Rathi V, Roth L, Burke J, Dhruva S, White S, Ross J. Valuation Adjustments for Services Reviewed by the Relative Value Scale Update Committee. JAMA Network Open 2026, 9: e2631317. PMID: 42678701, PMCID: PMC13535787, DOI: 10.1001/jamanetworkopen.2026.31317.Peer-Reviewed Original ResearchCitationsAltmetricAffordable Care Act Enhanced Subsidy Expiration: Characterizing Enrollees at Risk of Coverage Loss
Bhat S, Ross J. Affordable Care Act Enhanced Subsidy Expiration: Characterizing Enrollees at Risk of Coverage Loss. Journal Of General Internal Medicine 2026, 1-4. PMID: 42613401, DOI: 10.1007/s11606-026-10725-8.Commentaries, Editorials and LettersAssociation of GLP-1 receptor agonists, SGLT 2 inhibitors, DPP-4 inhibitors, and sulfonylureas with incident cancer in type 2 diabetes
Sklepinski S, Herrin J, Swarna K, Neumiller J, Galindo R, Umpierrez G, Ross J, Deng Y, Polley E, Mickelson M, McCoy R. Association of GLP-1 receptor agonists, SGLT 2 inhibitors, DPP-4 inhibitors, and sulfonylureas with incident cancer in type 2 diabetes. Diabetes Research And Clinical Practice 2026, 239: 113503. PMID: 42607727, DOI: 10.1016/j.diabres.2026.113503.Peer-Reviewed Original ResearchAltmetricPremarket Clinical Evidence Strength and Recalls of High-Risk Therapeutic Medical Devices
Mooghali M, Arshad F, Rathi V, Kadakia K, Everhart A, Ross J, Dhruva S. Premarket Clinical Evidence Strength and Recalls of High-Risk Therapeutic Medical Devices. JAMA Health Forum 2026, 7: e262626. PMID: 42566203, PMCID: PMC13451980, DOI: 10.1001/jamahealthforum.2026.2626.Peer-Reviewed Original ResearchAltmetricOnline Prescribing of GLP-1 Receptor Agonists.
Chetty A, Chen A, Ross J, Ramachandran R. Online Prescribing of GLP-1 Receptor Agonists. JAMA: The Journal Of The American Medical Association 2026, 336: 428-431. PMID: 42406378, PMCID: PMC13338841, DOI: 10.1001/jama.2026.9131.Peer-Reviewed Original ResearchCitationsAltmetricCommercial price variation in precision oncology testing across US hospitals
Mooghali M, Skydel J, Gross C, Dusetzina S, Walther Z, Lustberg M, Ross J, Wallach J. Commercial price variation in precision oncology testing across US hospitals. Health Affairs Scholar 2026, 4: qxag203. PMID: 42626283, PMCID: PMC13492076, DOI: 10.1093/haschl/qxag203.Peer-Reviewed Original ResearchCommercial Price Variation for Common Dermatologic Procedures.
Deitelzweig C, Dhawan R, King K, Skydel J, Ramachandran R, Ross J, Yeung H, Wallach J. Commercial Price Variation for Common Dermatologic Procedures. JAMA Dermatology 2026, 162: 845-848. PMID: 42307923, PMCID: PMC13276662, DOI: 10.1001/jamadermatol.2026.1585.Peer-Reviewed Original ResearchCitationsAltmetricEfficacy Measures Used in Alzheimer Disease Clinical Trials Between 2015 and 2025
Li C, Fu M, Berg K, Wallach J, Ling K, Wei R, Shi L, Ross J, Guan X. Efficacy Measures Used in Alzheimer Disease Clinical Trials Between 2015 and 2025. Neurology 2026, 107: e218373. PMID: 42492033, PMCID: PMC13445500, DOI: 10.1212/wnl.0000000000218373.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricFunding Source and the Online and Academic Impact of Cardiovascular Trials
Zahedi Tajrishi F, Bukhari S, Rashedi S, Hashemi A, Dreyfus I, Varunok N, Burton J, Chan You S, Ki Y, Redfors B, Piazza G, Wallach J, Curtis L, Kaul S, Cohen D, Mehran R, Geraldes F, Ross J, Leopold J, Krumholz H, Stone G, Bikdeli B. Funding Source and the Online and Academic Impact of Cardiovascular Trials. Journal Of The American College Of Cardiology 2026 PMID: 42484583, DOI: 10.1016/j.jacc.2026.06.023.Peer-Reviewed Original ResearchAltmetric
Academic Achievements & Community Involvement
Copy Link
Activities
activity JAMA
06/01/2023 - PresentJournal ServiceDeputy Editoractivity BMJ
2020 - 2023Journal ServiceAssociate Editoractivity JAMA Internal Medicine
04/01/2013 - 12/31/2019Journal ServiceAssociate Editoractivity Journal of General Internal Medicine
2011 - 2013Journal ServiceDeputy Editor
News
Copy Link
News
- July 07, 2026
An Online Secret Shopping Study Reveals Easy Access to GLP-1 Prescriptions with Limited Clinician Oversight
- March 05, 2026Source: Yale News
Cost of Physical Therapy Varies Widely from State-to-State
- November 03, 2025Source: JAMA
Dean Megan Ranney contributes to new report aimed at reducing firearm violence
- October 21, 2025Source: Yale News
IV Hydration Spas Lack Adequate Oversight, Study Finds
Get In Touch
Copy Link
Contacts
General Internal Medicine
P.O. Box 208093
New Haven, CT 06520-8093
United States
Locations
E.S. Harkness Memorial Hall, Building A
Academic Office
367 Cedar Street, Ste 405B
New Haven, CT 06510